Kidney, liver and colon products sit in the busiest corner of the supplement catalogue and the most exposed one. Buyers order them constantly, because demand is steady and repeat purchase is high. They are also the products most likely to be stopped at a customs desk, rejected by a retailer or pulled from a paid channel, because the language that sells them is the same language regulators treat as a drug claim. Getting these products right is therefore less a matter of finding a formula than of holding a line on naming, specification and labelling from the first sample onward.

Name the product, not the outcome

  • Workable: a product name plus a structure or function statement — “Kidney Support Capsules” with wording like “supports normal kidney function”, reviewed for the destination market.
  • Not workable: outcomes. Flushing, cleansing, detoxifying, repairing or regenerating a named organ describes a physiological result and, in most markets, needs prior authorisation the product will not have.
  • Keep the carton to the product name, specification and count. Marketing language belongs in reviewed copy, never printed onto the pack, because the pack follows the product into every market you later ship to.

Specify extracts by marker compound, not by herb

“Milk thistle” is not a specification. Two powders under that name can differ several-fold in what actually matters, so the specification has to fix the chemistry:

  • Standardisation: state the marker and its percentage — for example silymarin at a defined percentage for milk thistle, or a defined ratio for a whole-herb extract. Without a marker, the ingredient has no fixed identity and no reproducible dose.
  • Ratio versus standardised: a 10:1 extract and a standardised extract are different materials, and the milligram figure on the label means different things in each case. Declare which one you are using.
  • Carrier and excipient reality: many herbals are hygroscopic or poorly flowing, which decides whether the formula can be filled at all in the capsule size the brief asks for.
  • Identity testing: herbal supply chains are where adulteration lives. Lot-level identity confirmation, not just a certificate, is the control that catches substitution.

The laxative trap in colon products

Colon formulas are the clearest example of why formulation and marketing cannot be separated. The ingredients that produce a fast, obvious effect are usually stimulant laxatives — senna and its glycosides, cascara, and similar. In most markets those ingredients carry mandatory label warnings and duration limits, and they are restricted in some. That is a formulation and labelling decision with legal consequences, not a marketing choice. Two consequences follow:

  • If the brief says “make it work fast”, the honest answer is that the fast route carries warnings and market restrictions, and the customer should decide with that in front of them.
  • If the formula goes the fibre route instead, the constraint moves to texture and safety: bulking fibres such as psyllium are viscous and gritty, and taking them without enough liquid is a recognised choking hazard. That is why “take with a full glass of water” belongs on the label rather than in a leaflet.

What the label has to declare

  • Both numbers, where both exist — the total herbal blend weight and the standardised extract weight, so the label is not read as claiming more active than the fill contains.
  • Count and fill weight, matching the specification exactly; a mismatch between carton text and the certificate is the most common reason a shipment is held.
  • Warnings that the formula and the destination market actually require, applied from the first print run rather than added after a rejection.
  • The structure or function disclaimer where the destination market requires one next to any structure or function statement.

Testing is the real cost line

For organ-support herbal blends the QC burden is heavier than for a single synthetic vitamin, and it should be priced in from the start. Heavy metals and pesticide residues are the primary tests, driven by the fact that the material is plant-derived and multi-sourced. Microbiological limits matter for anything unsterilised, and identity testing protects the formula from substitution. Where a formula also contains a stimulant laxative, the marker compound has to be assayed to confirm the dose is what the label says.

MOQ, sampling and lead times

A practical starting point with a manufacturer set up for small batches is MOQ 500 units per SKU, samples in 3–5 days, and bulk production shipped within 7 days. Multi-herb blends move the sampling timeline, because each botanical has its own lead time and its own identity test, so build that into the launch date instead of discovering it afterwards.

How Haiyue Shengda works

We develop and fill capsules, softgels, gummies, tablets, liquid drops, powders, teas and personal-care formats in our own 5,000+ m² factory with 7 production lines and 34 machines, holding FDA facility registration, HACCP, cGMP and ISO 22000. Send us your brief, target market and intended dose form, and we will come back with a feasibility view, the specification points that need a decision, and indicative pricing.